We are live on ! Find out more
EXEL icon

Exelixis

295 hedge funds and large institutions have $5.18B invested in Exelixis in 2018 Q1 according to their latest regulatory filings, with 50 funds opening new positions, 106 increasing their positions, 93 reducing their positions, and 55 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more call options, than puts

Call options by funds: $82.8M | Put options by funds: $35.6M

14% more repeat investments, than reductions

Existing positions increased: 106 | Existing positions reduced: 93

9% less first-time investments, than exits

New positions opened: 50 | Existing positions closed: 55

1.94% less ownership

Funds ownership: 80.8%78.86% (-1.9%)

2% less funds holding

Funds holding: 302295 (-7)

29% less capital invested

Capital invested by funds: $7.27B → $5.18B (-$2.09B)

50% less funds holding in top 10

Funds holding in top 10: 63 (-3)

Holders
295
Holders Change
-7
Holders Change %
-2.32%
% of All Funds
6.75%
Holding in Top 10
3
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-50%
% of All Funds
0.07%
New
50
Increased
106
Reduced
93
Closed
55
Calls
$82.8M
Puts
$35.6M
Net Calls
+$47.2M
Net Calls Change
+$1.91M

EXEL Hedge Fund Activity: Q1 2018 in Review

295 of the 4,373 institutional investors tracked by Wall St. Rank reported a position in Exelixis (EXEL) for Q1 2018, worth a combined $5.18B — down 29% from $7.27B a quarter earlier.

Sellers outnumbered buyers: 55 funds closed out of EXEL and 50 opened new positions — a net loss of 5 holders — while 93 trimmed existing stakes and 106 added.

The largest buyer was JP Morgan Chase, adding an estimated $64.7M. The largest seller was Goldman Sachs, cutting an estimated $126M.

  • 295 institutional investors held Exelixis (EXEL) as of Q1 2018, down from 302 in Q4 2017.
  • Funds reported $5.18B of Exelixis stock for Q1 2018, down 29% quarter-over-quarter.
  • 50 funds opened new Exelixis positions in Q1 2018 and 55 closed out, a net change of -5 holders.
  • The largest Exelixis buyer in Q1 2018 was JP Morgan Chase, an estimated $64.7M added.
  • The largest Exelixis seller in Q1 2018 was Goldman Sachs, an estimated $126M sold.

Based on aggregated 13F filings for Q1 2018.